Prevalence of antinuclear antibodies in inflammatory bowel disease and seroconversion after biological therapy

Authors: García MJ, Rodríguez-Duque JC, Pascual M, Rivas C, Castro B, Raso S, López-Hoyos M, Arias-Loste MT, Rivero M.
Therap Adv Gastroenterol. 2022 Mar 2;15:17562848221077837. doi: 10.1177/17562848221077837. eCollection 2022. PubMed: 35251307
Mostrar Más
PMID: 35251307
Title: Prevalence of antinuclear antibodies in inflammatory bowel disease and seroconversion after biological therapy
Authors: García MJ, Rodríguez-Duque JC, Pascual M, Rivas C, Castro B, Raso S, López-Hoyos M, Arias-Loste MT, Rivero M.
Citation: Therap Adv Gastroenterol. 2022 Mar 2;15:17562848221077837. doi: 10.1177/17562848221077837. eCollection 2022.
First Author: García MJ
Journal/Book: Therap Adv Gastroenterol
Publication Year: 2022
Create Date: 2022/03/07
PMCID: PMC8894967
NIHMS ID:
DOI: 10.1177/17562848221077837